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ABSTRACT
Tamoxifen (TAM) is a drug used for treatment and prevention of breast cancer.
However, TAM has been reported to induce liver tumors in several animal models due to
overproduction of free radicals and lipid peroxidation. Thymoquinone (TQ), from Nigella
sativa seeds, is a Middle East natural medicine and it has been used to treat a number of
diseases, including cancer. The aim of my study was to investigate the effect of TQ and
TAM on tumor development, lipid peroxidation level, and total antioxidant capacity in
DMBA treated female Sprague-Dawley rats. Five groups of 10 rats (control, DMBA,
TAM, TQ, and TAM+TQ) were used. Mammary tumors were induced by DMBA which
was given by oral gavage to four groups: DMBA, DMBA+ TAM, DMBA+ TQ, and
DMBA+ TAM & TQ. The control group received tap water only. Starting three weeks
later, TAM and/or TQ were administered daily for 10 weeks. Mammary tumors were
found in two DMBA treated animals. There was coloration in the mammary glands in
four other DMBA treated animals. No mammary tumors or mammary gland coloration
was observed in other groups. Rats treated with TAM showed a significantly higher level
of lipid peroxidation when compared to control (P<0.05). However, the administration of
TQ together with TAM showed significant decrease in lipid peroxidation level compared
to treatment with TAM alone (P<0.05). Total antioxidant capacity did not differ among
the groups (P=0.791). Average body weight gain during 12 weeks differed significantly
among the groups (P<0.001). TAM treated rats had a lower body weight gain when
compared with other animals and this was not ameliorated by TQ. In conclusion, both
TAM and TQ appeared to prevent tumor induction by DMBA.TAM had two adverse
effects on the rats: increasing in lipid peroxidation levels and reduction in body weight
gain. TQ ameliorated the adverse effect of TAM on lipid peroxidation but not body
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weight gain. My study is the first to show the anticancer/antitoxic effects of TQ and TAM
together on mammary tumor and lipid peroxidation level. Data from this study suggested
that the combination therapy of TQ and TAM could be a safer anticancer drug than TAM
alone.
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Introduction
Breast Cancer
Breast cancer is the most common cancer among women, with more than 210,000
cases diagnosed in the United States alone every year (Siziopikou, 2013). Breast
carcinoma is a disease in which abnormal cells in the mammary glands divide and
multiply in an uncontrolled way. This disease is divided into two major types:
Non-invasive breast cancer (in situ): is an abnormal growth of the cells still
within the area in which it started. It is classified as ductal carcinoma in situ or
lobular carcinoma in situ.
•

Ductal carcinoma in situ: is the most common type of non-invasive
that presents in the duct and does not go through the duct walls into the
surrounding tissues.

•

Lobular carcinoma in situ: is a very early form of breast cancer that
develops within the lobules of the breast (Richie & Swanson, 2003).

A. Invasive breast cancer: is a type of breast cancer that starts in the ducts or
lobules and spread to nearby or distant tissue of the body. Paget’s disease is a
rare form of invasive breast cancer and it begins in the ducts and spreads to
the skin of the nipple and areola (Muttarak et al., 2011).
Reactive Oxygen Species and Oxidative Stress
Reactive oxygen species (ROS) have been implicated in the development of
breast cancer. ROS are products of normal cellular metabolism (Karihtala & Soini, 2007).
ROS are divided into free radicals and non-radical ROS. Free radicals, which contain one
or more unpaired electrons, include superoxide anion radical (O·

2),

the highly reactive
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hydroxyl radical (.OH), nitric oxide (.NO), and alkoxyl- (RO.) or peroxyl-(ROO.) radicals.
Non-radical ROS include hydrogen peroxide (H2O2), hypochloride (HOCI), and organic
hydroperoxide (ROOH) (Storz, 2005).
Reactive oxygen species are generated in our body by various endogenous factors
such as many enzymatic activities like proteins within the plasma membrane, lipid
metabolism within the peroxisomes, as well as the activity of various cytosolic enzymes
such as cyclooxygenases (Droge, 2002; Klaunig et al., 2010; Shinde et al., 2012).
Although all these endogenous sources contribute to the ROS production, the major
source of ROS is the mitochondria.
Most the energy that our cells need to live depends on a mitochondrial process
that requires oxygen (O2). In this process, which is called oxidative phosphorylation,
most of O2 (>95%) is used by the mitochondria to produce ATP. ATP generation is
coupled with a reaction in which O2 is reduced to H2O. Under certain conditions, some of
oxygen (<0.1% to 5%) is not completely oxidized to water but rather to the production of
reactive oxygen species, primarily the superoxide anion (Clark, 2002).
On the other hand, exogenous factor may also contribute to the production of
ROS. For example, ionizing radiation causes the formation of water radiolysis products
that contain some reactive oxygen species (Yamamori et al., 2012).
Reactive oxygen species normally exist in living cells in balance with
biochemical antioxidants. This balance is essential for the health and survival of
organisms. Oxidative stress occurs when this critical balance is disrupted because of
excess ROS and/or depletion of antioxidant or repair enzymes (Halliwell & Gutteridge,
2007). The results of oxidative stress may include increased cell proliferation, cell injury,
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senescence, and cell death ((Halliwell & Gutteridge, 2007).
). In addition, oxidative stress
plays an importantt role in the development of chronic diseases such as cancer, arthritis,
autoimmune disorders, cardiovascular and neurodegenerative diseases (Shinde et al.,
al.
2012).
Oxidative Stress and Cancer
Reactive oxygen species play a major role in tumor promotion by direct chemical
reaction or alteration of cellular processes (Vina et al., 2006). Cancer is a multistage
process defined by at least three stages: initiation, promotion, and progression (Figure 1).

Figure 1. Multistage process of cancer. A. initiation, B. promotion, and C. progression
(Sato, 2008).
Oxidative stress interacts with all three stages of this process. In the initiation
stage, which is caused by DNA alteration, ROS may produce DNA damage by
introducing gene mutations and structural alterations of the DNA. During the promotion
stage, which is caused by the expression of a latent phenotype of initiated cells, ROS can
contribute to abnormal gene expression, blockage of cell to cell communication,
communication and
modification of second messenger systems
systems. This results in an increase of cell
proliferation or a decrease in apoptosis of the initiated cell population. In the progression
pro
stage, defined as the development of a premalignant lesion into a malignant one,
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oxidative stress may participate by adding more DNA alterations to the initiated cell
population (Halliwell & Gutteridge, 2007; Klauniget et al., 1998).
Furthermore, reactive oxygen species can activate a variety of transcription
factors like nuclear factor kappa B (NF-κB), activating protein-1 (AP-1), and β-catenin.
The activation of these transcription factors contributes to tumor development by the
regulation of cellular proliferation, angiogenesis, and metastasis. For example, ROS have
been shown to have an impact on NF-κB regulation. Expression of NF-κB has been
shown to promote cell proliferation, whereas inhibition of NF-κB activation blocks cell
proliferation (Reuter et al., 2010). Additionally, cell lines from different cancers,
including colon, breast, pancreas, and squamous cell carcinoma, have all been reported to
express activated NF-κB (Bours et al., 1994).
Oxidative Stress and Lipid Peroxidation
Lipid peroxidation is defined as the oxidative damage of polyunsaturated lipids in
cell membranes, which contain two or more carbon-carbon double bonds (Evans &
Burdon, 1993). Many toxic products result from the formation of lipid peroxidation and
these have an impact at a site away from the area of their generation. Membrane lipids
such as mitochondrial membrane lipids and plasma membranes are more susceptible to
lipid peroxidation than other lipids. Therefore, the damage caused by lipid peroxidation
affects the function of the cells and their survival (Devasagayam et al., 2003).
Reactive oxygen species can change the membrane lipids, which contain a high
concentration of polyunsaturated fatty acid, and cause the lipid peroxidation (Barrera,
2012). The formation of lipid peroxidation results in reactive aldehydes, including
malondialdehde (MDA) and 4-hydroxy-2-noneal (4-HNE), which demonstrate high
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reactivity with protein and DNA (Klaunig et al., 2010). Malondialdehdes also react with
DNA bases and can introduce mutagenic lesions (Halliwell & Gutteridge, 2007).
Lipid peroxidation plays a major role in the pathogenesis of several diseases,
including atherogenesis, ischemia, and cancer (Halliwell & Gutteridge, 2007). Karihtala
et al. (2011) reported that the level of 4-hydroxy-2-nonenal, which is considered as a
marker of lipid peroxidation, increased during breast carcinogenesis. Several studies
suggested that lipid peroxidation products act as bioactive molecules in physiological and
pathological conditions. These compounds may affect and modulate several cell
functions including signal transduction, gene expression, cell proliferation, and the
response of the target cell (Parola et al., 1999).
Antioxidant Defense
An antioxidant is defined as a substance that when present at low concentrations
compared with those of an oxidizable substrate, such as fats, proteins, carbohydrates or
DNA, significantly delays or prevents oxidation of that substrate (Halliwell, 1990). Some
antioxidants, such as glutathione, and uric acid, are produced endogenusly. Other
antioxidants, like vitamins A, C and E, beta carotene, and lycopene, are acquired in food
(Lobo et al., 2010).
Antioxidants are divided into two groups based on mechanism of action: (1)
chain-breaking antioxidants, such as vitamin E and beta-carotene, break the chain of free
radical formation by donating an electron to stabilize existing free radical; and (2)
preventive antioxidants are enzymes that scavenge initiating radicals before they start an
oxidation chain (Scheibmeir et al., 2005).
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Antioxidant enzymes include superoxide dismutase, glutathione reductase,
glutathione-S-transferase, and glutathione peroxidase. Nonenzymatic antioxidants include
ascorbic acid, glutathione, melatonin, vitamin E, and uric acid (Halliwell & Gutteridge,
2007). The main role of superoxide dismutase is to catalyze the dismutation of
superoxide to hydrogen peroxide, which may prevent further generation of free radicals.
Glutathione interacts with free radicals by donating a hydrogen atom. This reaction
provides protection by neutralizing reactive hydroxyl radicals that are thought to be a
major source of free radical pathology, including cancer (Clark, 2002).
Antioxidants are consumed rapidly during the scavenging of ROS, so they need to
be regenerated or replaced by new endogenous formation or dietary - derived compounds
(Ghiselli et al., 2000). Antioxidants are provided by a healthy diet that includes variety of
fruits, vegetables, and herbs.
Nigella sativa and Thymoquinone
Nigella sativa, commonly known as black seed, is a Middle Eastern natural
medicine. In Islam, it is regarded as one of the greatest forms of healing medicine
available. The Prophet Muhammad, peace be upon him, once stated that the black seed
can heal every disease except death. Nigella sativa is an annual herbaceous plant
belonging to dicotyledon of the Ranunculaceae family. It grows in the Middle East,
Western Asia, and Europe. It has been employed for many years as a spice and food
preservative (Salama, 2010). The black seeds have been used in herbal medicine by
various cultures and civilizations to treat a number of diseases and as a supplement to
maintain good health (Butt & Sultan, 2010). Nigella sativa seed is used in folk medicine
as an antispasmodic, antihelminthic, antiseptic, antiarthritic, nerve tonic, appetizer,
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emmenagogue, and for the treatment of ascites, asthma and pustular dermatitis (Kanter et
al., 2003).
Nigella sativa contains both fixed and essential oils, proteins, alkaloids and
saponin. The major component of the essential oil is thymoquinone (TQ). Many studies
have indicated that TQ has antioxidant effects and has been shown to protect against
heart, liver and kidney damage in animal studies (Ali & Blunden, 2003).
Antioxidant /Anticancer Activities of Nigella sativa and Thymoquinone
The anticancer effects of Nigella sativa seed and its extracts have been
investigated by a large number of researchers using both in vivo animal models and in
vitro cancer cell lines. Bourgou et al. (2010) investigated the antioxidant and anticancer
activities of the essential oil from Tunisian Nigella sativa seed and its main components.
The results of this study indicated that the essential oil significantly inhibited ROS
production and thus exhibited the ability to protect cells from oxidative stress. In
addition, the anticancer activity of Nigella sativa was evaluated against human lung
carcinoma A-549 and colon adenocarcinoma DLD-1 cell lines. The oil was found to
significantly inhibit the growth of these cancer cell lines.
Topical application of Nigella sativa seed extract inhibited dimethylbenz [a]
anthracene/croton oil induced skin carcinogenesis in mice, delayed the onset of papilloma
formation and reduced the mean number of papillomas per mouse (Salomi et al., 1991).
In addition, the oral administration of Nigella sativa seeds gave protection against
methylnitrosourea induced oxidative stress and carcinogenesis in 80% of rats and Nigella
sativa seeds with honey together in 100% of Sprague-Dawley rats (Mabrouk et al., 2002).
In another study, the oral administration of Nigella sativa was shown to inhibit the
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induction and development of 1, 2- dimethylhydrazine (DMH) -induced aberrant crypt
foci, putative preneoplastic lesions for colon cancer, without any pathological changes in
the liver, kidneys, and spleen (Salim & Fukushima, 2003).
TQ has been reported to possess an anti-cancer effect against a large number of
cancer cell lines as well as in animal models. Li et al. (2010) evaluated the anticancer
effects of TQ through inhibition of the STAT3 signaling pathway in multiple myeloma
(MM) cells. Excess STAT3 protein may contribute to the growth of cancers by allowing
abnormal cells to grow and divide uncontrollably. The results of this study showed that
TQ could suppress both constitutive and inducible STAT3 activation in MM cells. Also,
they found that TQ inhibited the proliferation and accumulation of cells in sub-G1 phase
and apoptosis.
TQ was also reported to possess antitumor effect on MCF-7, MDA-MB-231 and
BT-474 breast cancer cell lines. TQ was able to reduce the migration and invasion of
these cells (Woo et al., 2011). Moreover, TQ showed promising anti-cancer activity
against hepatocellular carcinoma by the inhibition of HepG2 cells in a dose-dependent
manner (Ahmed et al., 2008).
Additionally, TQ was shown to inhibit the development of 1, 2-dimethylhydrazine (DMH)-induced oxidative stress during initiation and promotion of colon
cancer in Wistar rats (Harzallah et al., 2012). TQ also was found to be effective in
protecting mice against imidacloprid (IMI)-induced oxidative stress by enhancing
antioxidant defense mechanisms (Ince et al., 2013). In another study, TQ
supplementation prevented the development of diethylnitrosamine (DENA)-induced
initiation of liver cancer by decreasing oxidative stress (Ahmed et al., 2010).
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When TQ is combined with other anticancer drugs, it may enhance the
performance of these drugs. For example, Jafri et al. (2010) evaluated the antineoplastic
effect of TQ in combination with cisplatin, which is the most active chemotherapeutic
agent for the treatment of non-small cell lung cancer (NSCLC) and small cell lung cancer
(SCLC) using in vitro and in vivo techniques. The results showed that the administration
of TQ and cisplatin together inhibited proliferation of NSCLC and SCLC cell lines.
Additionally, the combination of TQ and cisplatin significantly reduced tumor volume
and tumor weight in a mouse model.
Another study by Arafa et al. (2011) examined the anti-proliferative effects of TQ
in doxorubicin-resistant human breast cancer cells. Doxorubicin is one of the clinically
most important anti-neoplastic agents and possesses a wide spectrum of anti-cancer
activity against various solid tumors, including breast cancer. However, the development
of doxorubicin resistance limits its use in treating breast cancer patients. Drug resistance
is associated with activation of signaling pathways such as the phosphatidylinositol-3
kinase (PI3K)/Akt or suppression of tumor suppressor genes, including PTEN. The
results of this study showed that TQ induces apoptosis in doxorubicin-resistant breast
cancer cells through up-regulation of PTEN at transcription level. The up-regulated
PTEN, in turn, inhibited the PI3K/Akt pathway and induced p53 and p21 protein
expression, thereby inducing G2/M cell cycle arrest and apoptosis.
Thymoquinone and Lipid Peroxidation
Lipid peroxidation is an important step in the pathogenesis of several disease
states. It is generated in small amounts by the effect of reactive oxygen species (Mylonas
& Kouretas, 1999). Antioxidants may delay the start or slow the rate of the lipid
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peroxidation reaction by inhibiting the formation of free radicals (Dauqan et al., 2011).
TQ has been reported to inhibit lipid peroxidation in several studies. Mansour et al.
(2002) reported that the oral administration of TQ reduced the hepatic and cardiac lipid
peroxidation in Swiss albino mice. In another study, the oral intake of Nigella sativa oil
for four weeks prior to induction of hepatotoxicity by D-galactosamine or carbon
tetrachloride gave complete protection against D-galactosamine (El-Dakhakhny et al.,
2000). In the same study, Nigella sativa oil showed a favorable effect on the serum lipid
pattern by decreasing serum total cholesterol, low density lipoprotein, and triglycerides,
and increasing high density lipoprotein level.
Tamoxifen
Tamoxifen (TAM) is an antiestrogen agent first synthesized in 1966 by Harper
and Walple at the Imperial Chemical Industries in Great Britain. The compound was
developed first as an antifertility drug but its antiestrogenic properties led to its
evaluation in the treatment of breast cancer in 1970 (Legha, 1988). In 1977, TAM was
approved for the prevention and treatment of breast cancer by the United States Food and
Drug Administration (Haskell, 2003).
TAM is used to treat women whose breast cancers express estrogen receptors
(ER) (White, 1999). Estrogens are steroid compounds that are important to develop and
maintain female reproductive organs. The primary source of estrogens is ovaries. The
granulosa cells, which surround an ovum within an ovarian follicle, secrete large amount
of estrogens during the days before ovulation, when the ovum and follicle are maturing
(Carlberg, 2011).
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The targets of estrogens include breast, all the other reproductive organs, brain,
bone, and liver. The tissues affected by estrogen molecules contain estrogen receptors,
which are protein molecules. Therefore, when estrogens circulate through the
bloodstream, they exert effects only on cells that contain estrogen receptors. There are
three known types of estrogen receptors: estrogen receptor alpha (ERα), estrogen receptor
beta (ERβ), and GPER1 (Carlberg, 2011).
Estrogen receptors normally reside in the cell’s nucleus, along with DNA
molecules. Therefore, when an estrogen molecule enters a cell and passes into the
nucleus, the estrogen binds to its receptor, activating it by altering its shape slightly. This
estrogen-receptor complex then binds to specific DNA sites, called estrogen response
elements. After it has attached to estrogen response elements in DNA, this estrogenreceptor complex binds to coactivator proteins and nearby genes become active. The
active genes produce molecules of messenger RNA, which guide the synthesis of specific
proteins. These proteins can then influence cell behavior in different ways, depending on
the cell type involved. In breast tissue, for example, estrogen triggers the proliferation of
cells lining the milk glands in the breast, thereby preparing the breast to produce milk if
the woman should become pregnant (Carlberg, 2011; National Cancer Institute).
Unfortunately, estrogen in some cases may contribute to the growth of breast
cancer by stimulating breast (cancer and normal) cell proliferation. That occurs when the
breast cells already possess DNA mutations that increase the risk of developing cancer.
Approximately 75% of all breast cancers are ER- positive, the type of breast cancer that
sensitive to estrogen (National Cancer Institute).
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A class of drug called selective estrogen receptor modulators (SERMs) can be
used to prevent or treat diseases of estrogen-responsive tissues (Carlberg, 2011). TAM is
the oldest and most prescribed SERM. TAM is chemically similar to estrogen, and binds
in the same site on the estrogen receptor as the natural hormone. Therefore, TAM exerts
its action by fitting into the estrogen receptors and blocking estrogen from acting on the
cells (Gadducci et al., 2005). This action is responsible for the pharmacological effects of
TAM.
Side Effects of Tamoxifen
TAM has been used in the therapy of advanced breast cancer since 1970.
Prevention trails have been initiated in which TAM is given to healthy women at high
risk of developing breast cancer. However, several studies indicated that the long-term
exposure to TAM may be associated with some side effects. TAM has been shown to
increase the incidence of liver tumors in several strains of rat. In humans, long-term
treatment of TAM is associated with an increased risk of endometrial cancer (Karki et al.,
2000).
TAM is metabolized by the human cytochrome P450s 3A4, 2C9, 2B6, 2C8,
2C19, 2D6, 1A1, 1A2, and 2A6 and is also an effective inducer of P450s 2B2, 2B1, and
3A in rat liver at doses comparable with the therapeutic doses used in humans (Dehal &
Kupfer, 1997). Cytochromes P450 are hemoproteins that catalyze the metabolism of a
diverse group of xenobiotics (drugs, environmental pollutants, pesticides, and herbicides)
and several biologically active endogenous compounds (steroids, fatty acids) (Sridar et
al., 2002). The major products of the metabolism of TAM are tamoxifen-N-oxide, formed
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by flavin containing monooxygenase, and N-desmethyl and 4-hydroxytamoxifen, formed
by cytochrome P450.
TAM has been shown to be a hepatocarcinogen in rats due to overproduction of
free radicals and lipid peroxidation during TAM metabolism (Ahotupa et al., 1994;
Nazarewicz et al., 2007; Tabassum et al., 2006). The hepatotoxicity-inducing mechanism
of TAM appears to involve mitochondrial injury, which causes steatosis because of
impaired beta-oxidation of fatty acids, and leads to generation of ROS and ATP depletion
(Farrel, 2002). Tabassum et al. (2006) reported that TAM induced lipid peroxidation and
inhibited enzymes of the antioxidant defense system in Swiss albino mice. Caballero et
al. (2001) reported that long- term treatment with TAM enhanced hepatocarcinogenesis
induced by p- dimethylaminoazobenzene in mice. In another study, the strong
hepatocarcinogenic effect of TAM was observed in the high-dose female rats (Williams
et al., 1993).
Administration of an antioxidant, such catechin, has been effective in preventing
the toxicity of TAM (Tabassum et al., 2007). El-Beshbishy (2005) reported that the oral
administration of dimethyl dimethoxy biphenyl dicarboxylate, which is a traditional
Chinese medicine, together with TAM resulted in increasing the antioxidant enzyme
activities and decreasing lipid peroxidation in female albino rats. Parvez et al. (2008)
investigated the effect of pre-treatment with taurine, a natural amino acid known to
possess antioxidant activity, on the toxicity of TAM in mouse liver mitochondria. The
results showed the pre-treatment of Swiss albino mice with taurine markedly lowered
mitochondrial lipid peroxidation, and restored enzymatic and non-enzymatic antioxidants
of mitochondria.
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Summary
In summary, breast cancer is the most common cancer in women worldwide.
TAM is a drug used for treatment and prevention of breast cancer. However, TAM has
been reported to induce liver tumors in several animal models due to overproduction of
free radicals and lipid peroxidation. On the other hand, TQ, from Nigella sativa oil,
shows promising effects against neoplastic activity in various tumor cell lines in vitro and
in vivo. This activity may be attributed to its inhibitory effects on cancer cell growth and
its capability for inducing apoptosis. In addition, TQ been reported to have antioxidant
effects and has been shown to protect against liver damage in several animal studies. TQ
also has been reported to enhance the performance of other anticancer drugs.
In my study, the combination of TAM and TQ may improve the performance of
TAM and expand the use of TAM in breast cancer treatment by overcoming the side
effects of TAM. Mammary tumors were induced in my study by 7, 12-dimethylbenz
(a)anthracene (DMBA). Additionally, rats’ livers were removed and weighed to
investigate the side effects of TAM.
Induction of Mammary Tumors in Rats
Mammary glands of several rat strains, mainly Sprague-Dawley and WistarFurth, are susceptible to transformation induced by chemical carcinogens. The most
widely used active chemical inducer of mammary carcinogenesis is 7, 12-dimethylbenz
(a)anthracene (DMBA) (Barros et al., 2004). DMBA is metabolized by P450 enzymes in
the rat liver. The oxidation of DMBA leads to the formation of reactive metabolites that
bind to DNA causing mutations and cancer initiation (Soujanya et al., 2011).
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Hypotheses
The purpose of my study was to investigate the efficacy of a combination of
thymoquinone and tamoxifen against 7, 12- dimethylbenz(a) anthracene (DMBA)
induced mammary carcinogenesis in female Sprague- Dawley rats. By measuring the
lipid peroxidation and total antioxidant capacity, as well as evaluating the number and the
sizes of tumors, I evaluated the effect of these drugs in preventing mammary cancer.
1. My first hypothesis was that the combination of TAM and TQ would decrease the
lipid peroxidation level in experimental groups more than TAM alone.
2. My second hypothesis was that the combination of TAM and TQ would increase
the total antioxidant capacity in TAM+ TQ group more than TAM alone.
3. Finally, I hypothesized that the combination of TQ and TAM would lead to a
decrease in the number or the size of tumors in experimental groups.
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Materials and Methods
Animals
Fifty female Sprague-Dawley rats were used in this study. All the animals came
from the Eastern Washington University Animal Facility. At the beginning of this study
the animals were 12 weeks old. IACUC approval was granted through Eastern
Washington University.
The rats were randomly assigned to five groups of 10 rats each. Mishra et al.
(2011) used six rats for their TAM group. The power of their experiment was 0.05 which
is so low due to the sample size. On the other hand, Singh et al. (2011) used 18 rats for
their TAM group. The power of their experiment was 1. I concluded that 10 rats for each
group would be sufficient for determining the effect of the drugs on the rats.
The 50 animals used in this study were randomly placed into five groups of
10.The groups were as follows:
TAM group: received a single dose of DMBA, and after three weeks they
received TAM daily for 10 weeks.
TQ group: received a single dose of DMBA, and after three weeks they received
TQ daily for 10 weeks.
TAM+ TQ group: received a single dose of DMBA, and after three weeks they
received TAM + TQ daily for 10 weeks.
DMBA group: received a single dose of DMBA, and tap water daily for 10 weeks
Control group: received tap water only, daily for 10 weeks.
All animals were housed in the Eastern Washington University Animal Facility.
The animals were placed on 12 hours light/dark cycle. The room temperature was
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26±1ºC, and humidity was 25-30%. The animals were housed in pairs in standard cages
and allowed free access to water and Teklad 8640 Standard Rodent Diet. The cages were
cleaned every seven days and changed every four weeks. Body weight was measured on
all animals every seven days to calculate the volume of drug doses.
Drugs
DMBA administration. Mammary tumors were induced by 7, 12dimethylbenz(a) anthracene (DMBA) (Barros et al., 2004). A single dose of DMBA
dissolved in corn oil was given by oral gavage to four groups: DMBA, TAM, TQ,
TAM+TQ. Starting three weeks later, TAM and/or TQ were administered daily for 10
weeks by oral gavage using the syringe and needles in Dr. Carlberg’s lab. In the fourth
week, the same dose of DMBA was given again to the same groups of animals due to an
error in needle length measurement.
DMBA was purchased from Sigma Aldrich and dissolved in corn oil. The
concentration of the solution was 20 mg DMBA per 1 ml corn oil (Barros et al., 2004).
The volume given to each rat was equal to its weight in kg times 1 ml. For example, if the
rat weight was 250 g the volume was 0.25 ml of the solution.
For oral gavage, I extended the rat’s head back using an index finger on top of the
head to raise the head so the esophagus was in a straight line. Next, I inserted the needle
into the rat’s mouth. Once the gavage needle was properly placed, the rounded end of the
needle was in the rat’s stomach, I slowly administered the dose. After administration, I
removed the needle from esophagus (University of Delaware, 2010).
DMBA is a carcinogenic agent, so some protection steps were performed before,
during, and after the DMBA administration. Before the administration, I covered all the
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surfaces with protective paper, and I wore a disposable lab coat with face shield mask.
Also, I placed absorbent sheets in the animal cages so I could tell if they vomited.
Moreover, DMBA administration was given under the hood that was also was covered by
protective paper. After the administration, I removed all the protective paper from the
surfaces, and the absorbent sheets from the cages. I put the disposal lab coat, face shield
mask, protective paper, and absorbent sheets in the hazard bags. Also, I cleaned all the
surfaces with soap and alcohol. Two weeks later, all the cages were washed twice in the
cage washer to ensure a clean environment for the animals. Furthermore, all the rats were
washed in warm water and placed under a heat lamp to make sure they dried completely.
Tamoxifen and thymoquinone administration. TAM was purchased from
Cayman Chemical. The drug arrived in a powder form, and I kept it at -20°C during the
experiment. The dose of TAM was 10 mg/kg /day (Soujanya et al., 2011). The total
volume of TAM needed for all of the 20 rats was determined. For an average animal
weight of 250 g the total volume of TAM was 50 mg. Therefore, I prepared a solution
containing 50 mg of TAM dissolved in 5 ml water daily. The dose for each rat was
calculated as follows: the rat weight in mg/1000.
TQ was purchased from Sigma Aldrich. The drug arrived in a crystal form, and I
kept it at room temperature in the lab drawers. The dose of TQ was 20 mg/kg/day (Jafri et
al., 2010). The total volume of TQ needed for all of the 20 rats was determined. For an
average animal weight of 250 g the total volume of TQ was 100 mg. I prepared a solution
containing 100 mg of TQ mixed with 10 ml of corn oil daily. The dose for each rat was
calculated as follows: the rat weight in mg/1000.
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The TAM + TQ group received the same volume of TAM and TQ in the same
oral gavage at the same time. The volume for 250 g rat was 0.25 ml of TAM solution and
0.25 of TQ solution.
The gavage needles were flushed with alcohol between animals. At the end of
each day, rats were observed for one hour after drug administration in case they vomited.
Surfaces, drugs containers, and needles were washed with soap and alcohol.
Evaluation of Mammary Tumors
I inspected all rats for mammary tumors at 3 weeks after administering DMBA.
The second evaluation was after five weeks of treatment and the last one was after 10
weeks of treatment. To begin this procedure, I held the rat by grasping the whole body
with my palm over the rat’s back, with forefinger behind the head and the thumb and
second finger under the opposite axilla. I turned the rat and palpated to detect any
mammary tumors (Assis et al., 2010).
Blood Collection
After 10 weeks I collected blood samples (up to 3 ml) from each rat by cardiac
puncture (Beeton et al., 2007). Before this process some preparation steps were
performed. I added 5 ml of distilled water to a heparin bottle. Needles 21G X 1.5 inch
with 3cc syringes were coated with heparin to prevent blood clot formation. I put paper
towels in the two chambers that I used for anesthesia and euthanasia. I added to the
anesthesia chamber 6 ml of isoflurane, and 15 ml of isoflurane to the euthanasia chamber.
Centrifuge tubes were labeled with rat identification numbers.
Each rat was anesthetized with isoflurane in the first chamber. When the rat was
unconscious, I removed it from the chamber and placed it on its back, with its nose in a
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nose cone filled with isoflurane-soaked cotton. Then I inserted a 21G X 1.5 inch heparincoated needle connected to a 3 cc syringe below and slightly to the left of the xiphoid
cartilage at the base of the sternum, at a 20° to 30° angle. I advanced the needle slowly,
applying very slight negative pressure on the barrel of the syringe. Blood flowed into the
needle when the tip entered a chamber of the heart. When collection was completed, the
rat was euthanized with a higher dose of isoflurane in the second chamber.
Blood samples were centrifuged at 600 ´ g, at 4°C for 10 minutes. I removed the
plasma and aliquoted it into three microtubes per rat, one for the lipid peroxidation assay,
one for the total antioxidant capacity assay, and a third one for Abrar Sindi’s study. For
the lipid peroxidation assay, I added 5 µL of antioxidant Butylated hydroxytoluene
(BHT) to each plasma sample to prevent further oxidation of lipid. Samples were labeled
and stored at -80°C until analysis.
Tumor Evaluation
After euthanasia rats were dissected and evaluated for tumors. Mammary tumors
were removed using a dissection tray, a scalpel, and a scissors. Then, I used a caliper to
measure the width, length, and height of the tumor. Tumor volume was calculated using
the formula: Volume =1/6πabc, where 'a'= width, 'b' = length and 'c' = height (Assis et al.,
2010). Also, photos were taken of the mammary tumors, as well as the coloration in
mammary glands. Moreover, whole livers from rats were removed and weighted.
Lipid Peroxidation Assay
Evidence of lipid peroxidation in plasma was measured by the OxiSelect TBARS
assay kit (Cell Biolabs, Inc., San Diego, California). According to the product manual the
thiobarbituric acid reactive substances (TBARS) assay kit is a tool for the direct
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quantitative measurement of malondialdehyde (MDA) in biological samples. MDA is a
secondary product of lipid peroxidation that is widely used as an indicator of lipid
peroxidation. The TBARS assay measured MDA in plasma samples using thiobarbituric
acid (TBA), which forms an adduct with MDA when incubated at 95 °C. The MDA-TBA
complex forms a pink color that can be read spectrophotometrically. The MDA level in
plasma samples was quantified by comparison to an MDA standard curve.
Preparation of standard curve. I prepared a dilution series of MDA standards in
the concentration range of 125 µM – 0 µM by diluting the MDA Standard in deionized
water according to Table 1 below.
Standard tubes

MDA Standard (µL)

Water (µL)

MDA Standard(µM)

1

125 µL

875 µL

125

2

250 µL of tube # 1

250 µL

62.5

3

250 µL of tube # 2

250 µL

31.25

4

250 µL of tube # 3

250 µL

15.63

5

250 µL of tube # 4

250 µL

7.81

6

250 µL of tube # 5

250 µL

3.91

7

250 µL of tube # 6

250 µL

1.95

8

250 µL of tube # 7

250 µL

0.98

9

0 µL

250 µL

0.0

Table 1: Preparation of MDN standards.
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Preparation of reagents.
TBA acid diluent: 2X TBA diluent was diluted (1:2) with deionized water.
TBA regent: I prepared a 5.2 mg/mL solution of TBA regent by weighing out
260 mg of thiobarbituric acid (TBA). 2X TBA diluent was added and mixed vigorously
until the powder was dissolved. I adjusted the pH of the solution to pH 3.5 with sodium
hydroxide solution.
Assay protocol. Each MDA-containing sample and standard was assayed in
duplicate.
1- 100 µL of MDA standard and plasma was added to separate centrifuge
tubes.
2- 100 µL of the SDS lysis solution was added to each tube and incubated
for 5 minutes at room temperature.
3- 250 µL of TBA regent was added to each plasma and MDA standard.
4- Each tube was closed and incubated at 95°C in a water bath for 60
minutes.
5- All the tubes were placed in an ice bath for 5 minutes, and then
centrifuged at 3000 rpm for 15 minutes.
6- The supernatant was removed from the plasma and MDA standard.
7- 300 µL of the supernatant was added to the new tube.
8- 300 µL of n-Butnol was added to each plasma and standard to prevent
the interference of hemoglobin and its derivatives.
9- All sample tubes were placed in a vortex mixer for 2 minutes.
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10- After that the tubes were centrifuged at 10,000´g in the cold room for 5
minutes.
11- 200 µL each plasma and MDA standard was transferred to 96-well flatbottomed microplate.
12- The absorbance was read at 532 nm using the spectrophotometer. The
reaction between MDA and thiobarbituric acid (TBA) yielded a pink
color, which peaks at 532 nm.
Total Antioxidant Capacity Assay
The total antioxidant capacity (TAC) of plasma was measured by the OxiSelect Total
Antioxidant Capacity (TAC) assay kit (Cell Biolabs, Inc., San Diego, California).
According to the product manual the TAC assay is based on measurement of the
reduction of copper (II) to copper (I) by viable antioxidants in a sample within a 96-well
microtiter plate. Upon reduction, the copper (I) ion will react with a coupling
chromogenic reagent that produces a color with a maximum absorbance at 490 and is
read in a spectrophotometer. The absorbance values are then compared to a standard
curve of uric acid antioxidant activity.
Preparation of uric acid standard curve. A uric acid standard stock solution
was prepared by weighing out uric acid powder for a 10 mg/mL or 60 mM solution in 1N
NaOH. The stock solution was used to prepare serial dilutions of uric acid in deionized
water, with the highest concentration at 1 mM diluted to 9 different concentrations with
0.0039 mM as the lowest, and the 10th sample as a blank sample containing only water.
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2 mM Uric Acid Antioxidant

Deionized

Resulting Uric Acid

Tubes

Standard (µL)

water (µL)

Concentration (mM)

1

500

500

1

2

500 of tube # 1

500

0.5

3

500 of tube # 2

500

0.25

4

500 of tube # 3

500

0.125

5

500 of tube # 4

500

0.0625

6

500 of tube # 5

500

0.03125

7

500 of tube # 6

500

0.0156

8

500 of tube # 7

500

0.0078

9

500 of tube # 8

500

0.0039

10

0

500

0.0

Table 2: Preparation of uric acid standards.
Preparation of reagents.
1X reaction buffer: reaction buffer was diluted (1:100) with phosphate buffered saline.
1X copper ion regent: copper ion reagent was diluted (1:100) with deionized water.
1X stop solution: stop solution was diluted (1:10) with deionized water.
Assay protocol. Each uric acid or plasma sample was tested in triplicate.
1- 20 µL of each uric acid standard or plasma was added to the 96-well plate.
2- 180 µL of the reaction buffer was added to each sample and standard and
mixed with a vortexer.
3- An initial, baseline absorbance was read at 490 nm wavelength.
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4- The reaction started when 50 µL of the copper ion reagent was added into
each well, and then incubated for 5 minutes on an orbital shaker.
5- The reaction was terminated with the addition of 50 µL of the stop
solution.
6- The plate was read at 490 nm wavelength.
7- The baseline readings were subtracted from these values to produce the
net absorbance values.
8- Antioxidant capacities of the samples were calculated first into “mM uric
acid equivalents” by comparison against the uric acid standard
concentration curve.
9- This value was then be used to obtain the “copper reducing equivalents”
by multiplying the uric acid equivalent concentrations by 2189 (µM
Cu2+/mM uric acid).
10- This final value was proportional to the sample’s total antioxidant capacity
and was used for data analysis.
Statistical Analysis
The number of rats with tumors and the number of rats with mammary gland
coloration were counted. No statistical analysis was performed.
Data for body weight gain between weeks one and 13, and liver weight were
determined to be normally distributed by using Shapiro-Wilk test. Therefore, the one-way
ANOVA test was used to analyze body weight gain and liver weight data.
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For total antioxidant capacity, a mean of triplicate measurements was calculated for
each animal. Data for total antioxidant capacity were not normally distributed. Therefore,
the Kruskal-Wallis test was used to analyze total antioxidant capacity data.
For lipid peroxidation levels, a mean of duplicate measurements was calculated for
each rat. Data for lipid peroxidation were not normally distributed. Therefore, the
Kruskal-Wallis test was used.
Lipid peroxidation, total antioxidant capacity, body weight gain, and liver weight
data were analyzed using Sigma Plot software. Values of P<0.05 were considered
significant.
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Results
Three rats from TQ group died, probably due to an error in TQ administration. TQ
was mixed with corn oil and that caused the needle to become slippery. The gavage
needle may have been inserted by mistake into the trachea instead of the esophagus. All
three rats had difficulty breathing after TQ administration and died the next day.
During the three times of mammary tumor inspection, I was unable to feel any
lumps that felt like tumors. After the dissection, there were mammary tumors in two
DMBA treated rats. No tumors were found in the other groups (Figure 2, Table 3). The
tumor volumes were 299.5 mm3, 351.86 mm3 . Additionally, there was coloration in
mammary glands in four other DMBA treated animals and no coloration was observed in
the other groups. Red to dark green color was noticed in mammary glands of four DMBA
treated animals (Figure 3).
For lipid peroxidation, the Kruskal-Wallis test showed that lipid peroxidation
levels differed significantly among groups (P=0.017, Figure 4). Dunn’s Multiple
Comparison test showed that the lipid peroxidation level was significantly higher in the
TAM group when compared with control group (P<0.05). Animals receiving TQ + TAM
treatment showed significantly lower lipid peroxidation levels than the TAM-treated
group (P<0.05).
For total antioxidant capacity, the Kruskal-Wallis test showed there was no
significant difference among the groups (P=0.791, Figure 5)
For liver weight, the one way ANOVA showed there was no significant
difference among the groups (P=0.163, Figure 6). In addition, liver looked normal and
there was no visible sign of liver tumor.
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Average body weight gain differed significantly among the groups (P<0.001,
Figure 7). Pairwise Multiple Comparison procedures showed that treatment of animals
with TAM resulted in a significantly lower body weight gain when compared with
control (P<0.001), DMBA (P<0.001) and TQ (P=0.012) groups. Animals receiving TQ
+TAM treatment showed a significantly lower body weight gain when compared with
control (P<0.001), DMBA (P<0.001) and TQ (P=0.002) groups.
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Control

DMBA

TAM

TQ

TAM+TQ

Tumor

0

2

0

0

0

Coloration

0

4

0

0

0

Total

0/10

6/10

0/10

0/7

0/10

Table3. Table shows the number of rats with mammary tumors or mammary gland
coloration in control, DMBA, TAM, TQ, TAM+TQ groups.

Figure 2. Mammary tumor in one of DMBA treated rats.
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Figure 3. Mammary gland coloration in two of the DMBA trated rats.

31

0.7

b
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0.6

Lipid peroxidation levels (nm/ml)

ab
0.5

a
a
0.4

0.3

0.2

0.1

0.0
Column: 1

Control

Column: 2

DMBA

Column: 3

TAM

Column: 4

TQ

Column: 5

TAM+TQ

Figure 4. Lipid peroxidation levels in control, DMBA, TAM, TQ, TAM+TQ groups.
The Kruskal-Wallis test showed that there was a significant difference among the groups
(P=0.017). Lipid peroxidation level was significantly higher in the TAM group when
compared to control and TAM +TQ groups (P<0.05). Treatment groups that do not share
letters (a or b) are significantly different.
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1.8

Total antioxidant capacity (nm/ml)

1.6

1.4

1.2

1.0

0.8

0.6

0.4

0.2

0.0

Column: 1

Control

Column: 2

DMBA

Column: 3

TAM

Column: 4

TQ

Column: 5
TAM+TQ

Figure 5. Total antioxidant capacity in control, DMBA, TAM, TQ, TQ+TAM groups.
The Kruskal-Wallis test showed there was no significant difference among the groups
(P=0.791)
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Figure 6. Values are mean and ± S.D. for liver weight in scaled to body weight in
control, DMBA, TAM, TQ, TQ+TAM groups. One-way ANOVA showed there was no
significant difference among the groups (P=0.163).
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35
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25

b
b

20
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TQ

TAM+TQ

Figure 7. Values are mean and ± S.D. for body weight gain during 12 weeks. One-way
ANOVA showed a significant difference among the groups (P<0.001). Treatment of
animals with TAM resulted in a significantly lower body weight gain when compared
with control (P<0.001), DMBA (P<0.001) and TQ (P=0.012) groups. Animals receiving
TQ +TAM treatment showed a significantly lower body weight gain when compared with
control (P<0.001), DMBA (P<0.001) and TQ (P=0.002) groups. Treatment groups that
share letters (a or b) are similar to one another.
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Discussion
Mammary Tumors
In my study, I used DMBA as a carcinogen to induce mammary tumors in female
Sprague-Dawley rats. The mechanism by which DMBA causes cancer is based on the
metabolism of DMBA. Soujanya et al. (2011) reported that DMBA is metabolized in the
microsomes of both liver and mammary gland. The toxic manifestation of DMBA is
associated with its oxidative metabolism leading to the formation of reactive metabolites
capable of generating free radicals, which play a major role in the etiology of cancer.
The results of my study showed that there were mammary tumors in two DMBA
treated animals. Additionally, there were four other DMBA treated rats with mammary
gland coloration. Perumal et al. (2005) identified tumor cells in their study by the
appearance of a red mass under the epithelial layer of mammary pad. Therefore, 60% of
my DMBA treated rats developed mammary cancer. However, there were no mammary
tumors or mammary gland coloration in control, TAM, TQ, TAM+TQ groups, potentially
due to the protective role of both TAM and TQ.
TAM is widely used in the prevention and treatment of breast cancer. TAM works
against breast cancer by interfering with the activity of estrogen. Estrogen stimulates the
growth of breast cancer cells. TAM binds to estrogen receptors and blocks estrogen from
acting on the cells. In animal models, TAM was shown to be effective in preventing the
occurrence of mammary tumors (Soujanya et al., 2011). Perumal et al. (2005) reported
that the administration of TAM with riboflavin, niacin and coenzyme Q10, which are
known to have antioxidant activity, resulted in decreasing mammary tumors in female
Sprague-Dawley rats.
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On the other hand, many studies have indicated that TQ has an anti-cancer effect
against different carcinogenic agents or cancer cell lines. Woo et al. (2011) reported that
TQ possesses an anti-tumor effect on MCF-7, MDA-MB-231 and BT-474 breast cancer
cell lines. TQ was able to reduce the migration and invasion of these cells. Ahmed et al.
(2010) reported that TQ supplementation prevented the development of
diethylnitrosamine (DENA)-induced initiation of liver cancer by decreasing oxidative
stress.
Additionally, the combination of TQ with other anticancer drugs was shown to
improve the performance of these drugs. Jafri et al. (2010) evaluated the antineoplastic
effect of TQ in combination with cisplatin, which is the most active chemotherapeutic
agent for the treatment of non-small cell lung cancer (NSCLC) and small cell lung cancer
(SCLC) using in vitro and in vivo techniques. The results showed that the administration
of TQ and cisplatin together inhibited proliferation of NSCLC and SCLC cell lines. Also,
the combination of TQ and cisplatin significantly reduced tumor volume and tumor
weight in a mouse model.
The results of my study indicated that both TQ and TAM alone and together have
a protective role against DMBA-induced mammary tumors in female Sprague-Dawley
rats. Additionally, the results of this study show for the first time that the combination
therapy of TQ and TAM prevented the development of mammary cancer. Therefore, my
data provide evidence to implicate TQ alone or in combination with TAM in breast
cancer prevention and treatment.
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Lipid Peroxidation Levels
Lipid peroxidation is generated by the effect of ROS and it is a common feature
of several diseases, including cancer. Lipid peroxidation levels were assessed using
TBARS assay kit. This assay depends on the measurement of MDA in plasma samples.
MDA is a result of lipid peroxidation. It has been reported that MDA may cause DNA
damage (Halliwell & Gutteridge, 2007).
The results of my study showed that the lipid peroxidation level was significantly
higher in the TAM group compared with the control group. In addition, animals receiving
TQ + TAM treatment showed significantly lower lipid peroxidation levels than the TAMtreated group.
Many studies have shown that TAM could be a hepatocarcinogen due to
overproduction of free radicals and lipid peroxidation during hepatic TAM metabolism.
Tabassum et al. (2006) reported that TAM induced lipid peroxidation and inhibited
enzymes of the antioxidant defense system in Swiss albino mice. Caballero et al. (2001)
reported that long- term treatment with TAM enhanced hepatocarcinogenesis induced by
p- dimethylaminoazobenzene in mice. However, administration of an antioxidant, such
catechin, has been effective in preventing the toxicity of TAM (Tabassum et al., 2007).
El-Beshbishy (2005) reported that the oral administration of dimethyl dimethoxy
biphenyl dicarboxylate, which is a traditional Chinese medicine, together with TAM
resulted in lower lipid peroxidation in female rats.
In contrast, TQ has been reported to decrease lipid peroxidation levels in several
studies. TQ and other antioxidants delay the start of the lipid peroxidation reaction by
inhibiting the formation of ROS. Mansour et al. (2002) reported that the oral
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administration of TQ reduced hepatic and cardiac lipid peroxidation in Swiss albino
mice. In another study, the oral intake of Nigella sativa oil for four weeks prior to
induction of hepatotoxicity by D-galactosamine gave complete protection against Dgalactosamine (El-Dakhakhny et al., 2000). In the same study, Nigella sativa oil showed
a favorable effect on the serum lipid pattern by decreasing serum total cholesterol, low
density lipoprotein, and triglycerides, and increasing high density lipoprotein level.
In my study, TAM did not affect liver weight which suggested that there was no
liver tumor. However, TAM treated animals showed a significantly higher level of lipid
peroxidation when compared to control. The administration of TQ together with TAM
showed significant decrease in lipid peroxidation level compared to treatment with TAM
alone. Data from this study show for the first time that the combination therapy of TQ
and TAM may help to overcome this side effect of TAM. TQ is a natural medicine and
many studies have indicated that there were no side effects observed with TQ
administration. Therefore, the combination therapy could be a powerful and safe drug in
prevention and treatment of breast cancer.
Total Antioxidant Capacity
Total antioxidant capacity was assessed using the OxiSelect Total Antioxidant
Capacity assay kit. Antioxidant defense helps to protect the body from free radicals and
their effects. The result of my study showed that total antioxidant capacity did not differ
among the groups. There could be two reasons that total antioxidant capacity did not
differ among groups. The dosage of TQ used, 20 mg/kg, may not have been sufficient to
increase antioxidant level. Alternatively, the assay kit may not have measured the total
antioxidant capacity accurately in plasma samples.
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Several studies have indicated that TQ possesses antioxidant activity and that
plays a major role in inhibiting the development of tumors. Harzallah et al. (2012)
reported that TQ was shown to inhibit the development of 1, 2-dimethyl-hydrazine
(DMH)-induced oxidative stress during initiation and promotion of colon cancer in
Wistar rats. In the same study, TQ treated rats showed a significantly higher level of the
antioxidant enzymes catalase, superoxide dismutase, and glutathione peroxidase levels
when compared to control rats. Ince et al. (2013) reported that TQ was effective in
protecting mice against imidacloprid (IMI)-induced oxidative stress by enhancing
superoxide dismutase, catalase, and glutathione peroxidase levels.
In contrast, long-term administration of TAM is accompanied by toxicity and
poor antioxidant defenses. However, El-Beshbishy (2005) reported that the toxicity of
TAM was abolished when combined with dimethyl dimethoxy biphenyl dicarboxylate,
which is a traditional Chinese medicine. The oral administration of combination therapy
resulted in increasing SOD, CAT and GPX levels in female rats.
In my study, TQ did not improve the antioxidant activity of TAM+TQ group. In
future studies an alteration in TQ doses will be useful to determine the effect of TQ in
improving the antioxidant activities. Choosing a different assay kit might lead to different
results.
Body Weight Gain
Total body weight gain over 12 weeks differed significantly among groups of
animals. Treatment of animals with TAM in both TAM and TAM+TQ groups resulted in
a significantly lower body weight gain when compared with other groups. TQ by itself
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did not reduce body weight gain, but also did not affect TAM-induced reduction in
weight gain.
Wade & Heller (1993) reported that the daily administration of TAM prevented
body weight gain in rats and this was associated with a significant reduction in daily food
intake. In addition, the reduction of body weight gain may be related to other effects of
TAM on body composition, adipose tissue, and energy expenditure reported in rats.
However, the effect of TAM on body weight in women is controversial. Data from two
clinical trials indicated that at least obese women treated with TAM had lower body mass
index than those not receiving the drug (Manni, et al., 2010). The results of my study
showed that TAM reduced weight gain and this effect was not ameliorated by TQ.
Conclusion
The purpose of my study was to investigate the effects of TQ and TAM on tumor
development, lipid peroxidation level, and total antioxidant capacity in DMBA treated
female Sprague-Dawley rats. My study showed that both TQ and TAM successfully
prevented the development of mammary tumors. Moreover, the oral administration of
TAM for 10 weeks increased the level of lipid peroxidation. Administration of TQ along
with TAM ameliorated this effect of TAM. Therefore, the combination therapy of TQ
and TAM could be a safer anti-cancer drug than TAM alone. In addition, the daily
administration of TAM resulted in reduction in weight gain. TQ, however, did not affect
body weight gain by itself, and did not prevent the reduction in weight gain caused by
TAM. Total antioxidant capacity did not differ among the groups.
My study shows for the first time that the combination of TQ and TAM
successfully prevents mammary tumor development and reduces lipid peroxidation
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induced by TAM. My data suggest that TQ alone or in combination with TAM have
potential utility in breast cancer prevention and treatment. Clinical studies are required to
evaluate the efficacy of adding TQ to TAM for treatment of breast cancer in women.
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